{"transactions":[{"id":723878,"issuer":{"id":6306,"kind":"organization","name":"IMMUNIC, INC."},"owners":[{"id":17364,"kind":"person","name":"HOWSON TAMAR D","position":1,"cik":"0001202286","reported_name":"HOWSON TAMAR D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2026-06-29T20:33:14.000Z","date":"2026-06-29","kind":"grant","planned":false,"acquired":true,"shares":25370,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents options to purchase shares of common stock conditionally approved by the Board of Directors on March 27, 2026, subject to approval of an amendment to the Company's 2019 Omnibus Equity Incentive Plan, as amended, by the Company's stockholders, which approval was obtained at the Company's 2026 Annual Meeting of Stockholders held on June 29, 2026."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option is fully vested as of March 27, 2026."}],"balance_after":25370,"derivative":{"exercise_price":10.9,"expiration_date":"2036-03-27","underlying":"Common Stock","underlying_shares":25370},"source":{"system":"sec-edgar","filing":"0001193805-26-000889","document":"e665609_4-howson.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1280776/000119380526000889/e665609_4-howson.xml","form_type":"4"}},{"id":1117693,"issuer":{"id":6306,"kind":"organization","name":"IMMUNIC, INC."},"owners":[{"id":17364,"kind":"person","name":"HOWSON TAMAR D","position":1,"cik":"0001202286","reported_name":"HOWSON TAMAR D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2025-06-09T20:09:04.000Z","date":"2025-06-05","kind":"grant","planned":false,"acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in monthly increments over a period of one year from the grant date."}],"balance_after":150000,"derivative":{"exercise_price":0.7729,"expiration_date":"2035-06-05","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001193805-25-000843","document":"e664612_4-howson.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1280776/000119380525000843/e664612_4-howson.xml","form_type":"4"}},{"id":1481903,"issuer":{"id":6306,"kind":"organization","name":"IMMUNIC, INC."},"owners":[{"id":17364,"kind":"person","name":"HOWSON TAMAR D","position":1,"cik":"0001202286","reported_name":"HOWSON TAMAR D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2024-06-12T20:05:19.000Z","date":"2024-06-11","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in monthly increments over a period of one year from the grant date."}],"balance_after":100000,"derivative":{"exercise_price":1.27,"expiration_date":"2034-06-11","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001193805-24-000784","document":"e663703_4-howson.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1280776/000119380524000784/e663703_4-howson.xml","form_type":"4"}},{"id":1591221,"issuer":{"id":6306,"kind":"organization","name":"IMMUNIC, INC."},"owners":[{"id":17364,"kind":"person","name":"HOWSON TAMAR D","position":1,"cik":"0001202286","reported_name":"HOWSON TAMAR D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2024-03-07T02:52:18.000Z","date":"2024-03-04","kind":"grant","planned":false,"acquired":true,"shares":64959,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On March 4, 2024, the stockholders of Immunic, Inc. approved a proposal to reduce the exercise price of all employee stock options having an exercise price above $3.00 per share (the \"Eligible Options\") to the greater of $1.72 and 110% of the closing price on a future repricing date to be set by the Board of Directors. The Board of Directors then determined that the exercise price of all Eligible Options will be repriced to $1.72 per share, which is greater than 110% of the closing price of the Common Stock on March 4, 2024, the repricing date set by the Board of Directors. Accordingly, this Form 4 reflects the cancellation of each Eligible Option and the reissuance of all Eligible Options at an exercise price of $1.72 per share. Following the repricing, each Eligible Option retains its respective original vesting schedule and expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On March 4, 2024, the stockholders of Immunic, Inc. approved a proposal to reduce the exercise price of all employee stock options having an exercise price above $3.00 per share (the \"Eligible Options\") to the greater of $1.72 and 110% of the closing price on a future repricing date to be set by the Board of Directors. The Board of Directors then determined that the exercise price of all Eligible Options will be repriced to $1.72 per share, which is greater than 110% of the closing price of the Common Stock on March 4, 2024, the repricing date set by the Board of Directors. Accordingly, this Form 4 reflects the cancellation of each Eligible Option and the reissuance of all Eligible Options at an exercise price of $1.72 per share. Following the repricing, each Eligible Option retains its respective original vesting schedule and expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On March 4, 2024, the stockholders of Immunic, Inc. approved a proposal to reduce the exercise price of all employee stock options having an exercise price above $3.00 per share (the \"Eligible Options\") to the greater of $1.72 and 110% of the closing price on a future repricing date to be set by the Board of Directors. The Board of Directors then determined that the exercise price of all Eligible Options will be repriced to $1.72 per share, which is greater than 110% of the closing price of the Common Stock on March 4, 2024, the repricing date set by the Board of Directors. Accordingly, this Form 4 reflects the cancellation of each Eligible Option and the reissuance of all Eligible Options at an exercise price of $1.72 per share. Following the repricing, each Eligible Option retains its respective original vesting schedule and expiration date."}],"balance_after":64959,"derivative":{"exercise_price":1.72,"underlying":"Common Stock","underlying_shares":64959},"source":{"system":"sec-edgar","filing":"0001193805-24-000325","document":"e619339_4-howson.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1280776/000119380524000325/e619339_4-howson.xml","form_type":"4"}},{"id":1591220,"issuer":{"id":6306,"kind":"organization","name":"IMMUNIC, INC."},"owners":[{"id":17364,"kind":"person","name":"HOWSON TAMAR D","position":1,"cik":"0001202286","reported_name":"HOWSON TAMAR D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2024-03-07T02:52:18.000Z","date":"2024-03-04","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":10000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On March 4, 2024, the stockholders of Immunic, Inc. approved a proposal to reduce the exercise price of all employee stock options having an exercise price above $3.00 per share (the \"Eligible Options\") to the greater of $1.72 and 110% of the closing price on a future repricing date to be set by the Board of Directors. The Board of Directors then determined that the exercise price of all Eligible Options will be repriced to $1.72 per share, which is greater than 110% of the closing price of the Common Stock on March 4, 2024, the repricing date set by the Board of Directors. Accordingly, this Form 4 reflects the cancellation of each Eligible Option and the reissuance of all Eligible Options at an exercise price of $1.72 per share. Following the repricing, each Eligible Option retains its respective original vesting schedule and expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On March 4, 2024, the stockholders of Immunic, Inc. approved a proposal to reduce the exercise price of all employee stock options having an exercise price above $3.00 per share (the \"Eligible Options\") to the greater of $1.72 and 110% of the closing price on a future repricing date to be set by the Board of Directors. The Board of Directors then determined that the exercise price of all Eligible Options will be repriced to $1.72 per share, which is greater than 110% of the closing price of the Common Stock on March 4, 2024, the repricing date set by the Board of Directors. Accordingly, this Form 4 reflects the cancellation of each Eligible Option and the reissuance of all Eligible Options at an exercise price of $1.72 per share. Following the repricing, each Eligible Option retains its respective original vesting schedule and expiration date."}],"balance_after":0,"derivative":{"exercise_price":3.4,"expiration_date":"2032-06-15","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001193805-24-000325","document":"e619339_4-howson.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1280776/000119380524000325/e619339_4-howson.xml","form_type":"4"}},{"id":1591219,"issuer":{"id":6306,"kind":"organization","name":"IMMUNIC, INC."},"owners":[{"id":17364,"kind":"person","name":"HOWSON TAMAR D","position":1,"cik":"0001202286","reported_name":"HOWSON TAMAR D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2024-03-07T02:52:18.000Z","date":"2024-03-04","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":10000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On March 4, 2024, the stockholders of Immunic, Inc. approved a proposal to reduce the exercise price of all employee stock options having an exercise price above $3.00 per share (the \"Eligible Options\") to the greater of $1.72 and 110% of the closing price on a future repricing date to be set by the Board of Directors. The Board of Directors then determined that the exercise price of all Eligible Options will be repriced to $1.72 per share, which is greater than 110% of the closing price of the Common Stock on March 4, 2024, the repricing date set by the Board of Directors. Accordingly, this Form 4 reflects the cancellation of each Eligible Option and the reissuance of all Eligible Options at an exercise price of $1.72 per share. Following the repricing, each Eligible Option retains its respective original vesting schedule and expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On March 4, 2024, the stockholders of Immunic, Inc. approved a proposal to reduce the exercise price of all employee stock options having an exercise price above $3.00 per share (the \"Eligible Options\") to the greater of $1.72 and 110% of the closing price on a future repricing date to be set by the Board of Directors. The Board of Directors then determined that the exercise price of all Eligible Options will be repriced to $1.72 per share, which is greater than 110% of the closing price of the Common Stock on March 4, 2024, the repricing date set by the Board of Directors. Accordingly, this Form 4 reflects the cancellation of each Eligible Option and the reissuance of all Eligible Options at an exercise price of $1.72 per share. Following the repricing, each Eligible Option retains its respective original vesting schedule and expiration date."}],"balance_after":0,"derivative":{"exercise_price":14.77,"expiration_date":"2031-06-10","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001193805-24-000325","document":"e619339_4-howson.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1280776/000119380524000325/e619339_4-howson.xml","form_type":"4"}},{"id":1591218,"issuer":{"id":6306,"kind":"organization","name":"IMMUNIC, INC."},"owners":[{"id":17364,"kind":"person","name":"HOWSON TAMAR D","position":1,"cik":"0001202286","reported_name":"HOWSON TAMAR D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2024-03-07T02:52:18.000Z","date":"2024-03-04","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":15000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On March 4, 2024, the stockholders of Immunic, Inc. approved a proposal to reduce the exercise price of all employee stock options having an exercise price above $3.00 per share (the \"Eligible Options\") to the greater of $1.72 and 110% of the closing price on a future repricing date to be set by the Board of Directors. The Board of Directors then determined that the exercise price of all Eligible Options will be repriced to $1.72 per share, which is greater than 110% of the closing price of the Common Stock on March 4, 2024, the repricing date set by the Board of Directors. Accordingly, this Form 4 reflects the cancellation of each Eligible Option and the reissuance of all Eligible Options at an exercise price of $1.72 per share. Following the repricing, each Eligible Option retains its respective original vesting schedule and expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On March 4, 2024, the stockholders of Immunic, Inc. approved a proposal to reduce the exercise price of all employee stock options having an exercise price above $3.00 per share (the \"Eligible Options\") to the greater of $1.72 and 110% of the closing price on a future repricing date to be set by the Board of Directors. The Board of Directors then determined that the exercise price of all Eligible Options will be repriced to $1.72 per share, which is greater than 110% of the closing price of the Common Stock on March 4, 2024, the repricing date set by the Board of Directors. Accordingly, this Form 4 reflects the cancellation of each Eligible Option and the reissuance of all Eligible Options at an exercise price of $1.72 per share. Following the repricing, each Eligible Option retains its respective original vesting schedule and expiration date."}],"balance_after":0,"derivative":{"exercise_price":12.3,"expiration_date":"2030-07-02","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001193805-24-000325","document":"e619339_4-howson.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1280776/000119380524000325/e619339_4-howson.xml","form_type":"4"}},{"id":1591217,"issuer":{"id":6306,"kind":"organization","name":"IMMUNIC, INC."},"owners":[{"id":17364,"kind":"person","name":"HOWSON TAMAR D","position":1,"cik":"0001202286","reported_name":"HOWSON TAMAR D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2024-03-07T02:52:18.000Z","date":"2024-03-04","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":9986,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On March 4, 2024, the stockholders of Immunic, Inc. approved a proposal to reduce the exercise price of all employee stock options having an exercise price above $3.00 per share (the \"Eligible Options\") to the greater of $1.72 and 110% of the closing price on a future repricing date to be set by the Board of Directors. The Board of Directors then determined that the exercise price of all Eligible Options will be repriced to $1.72 per share, which is greater than 110% of the closing price of the Common Stock on March 4, 2024, the repricing date set by the Board of Directors. Accordingly, this Form 4 reflects the cancellation of each Eligible Option and the reissuance of all Eligible Options at an exercise price of $1.72 per share. Following the repricing, each Eligible Option retains its respective original vesting schedule and expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On March 4, 2024, the stockholders of Immunic, Inc. approved a proposal to reduce the exercise price of all employee stock options having an exercise price above $3.00 per share (the \"Eligible Options\") to the greater of $1.72 and 110% of the closing price on a future repricing date to be set by the Board of Directors. The Board of Directors then determined that the exercise price of all Eligible Options will be repriced to $1.72 per share, which is greater than 110% of the closing price of the Common Stock on March 4, 2024, the repricing date set by the Board of Directors. Accordingly, this Form 4 reflects the cancellation of each Eligible Option and the reissuance of all Eligible Options at an exercise price of $1.72 per share. Following the repricing, each Eligible Option retains its respective original vesting schedule and expiration date."}],"balance_after":0,"derivative":{"exercise_price":9.54,"expiration_date":"2029-10-11","underlying":"Common Stock","underlying_shares":9986},"source":{"system":"sec-edgar","filing":"0001193805-24-000325","document":"e619339_4-howson.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1280776/000119380524000325/e619339_4-howson.xml","form_type":"4"}},{"id":1591216,"issuer":{"id":6306,"kind":"organization","name":"IMMUNIC, INC."},"owners":[{"id":17364,"kind":"person","name":"HOWSON TAMAR D","position":1,"cik":"0001202286","reported_name":"HOWSON TAMAR D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2024-03-07T02:52:18.000Z","date":"2024-03-04","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":19973,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On March 4, 2024, the stockholders of Immunic, Inc. approved a proposal to reduce the exercise price of all employee stock options having an exercise price above $3.00 per share (the \"Eligible Options\") to the greater of $1.72 and 110% of the closing price on a future repricing date to be set by the Board of Directors. The Board of Directors then determined that the exercise price of all Eligible Options will be repriced to $1.72 per share, which is greater than 110% of the closing price of the Common Stock on March 4, 2024, the repricing date set by the Board of Directors. Accordingly, this Form 4 reflects the cancellation of each Eligible Option and the reissuance of all Eligible Options at an exercise price of $1.72 per share. Following the repricing, each Eligible Option retains its respective original vesting schedule and expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On March 4, 2024, the stockholders of Immunic, Inc. approved a proposal to reduce the exercise price of all employee stock options having an exercise price above $3.00 per share (the \"Eligible Options\") to the greater of $1.72 and 110% of the closing price on a future repricing date to be set by the Board of Directors. The Board of Directors then determined that the exercise price of all Eligible Options will be repriced to $1.72 per share, which is greater than 110% of the closing price of the Common Stock on March 4, 2024, the repricing date set by the Board of Directors. Accordingly, this Form 4 reflects the cancellation of each Eligible Option and the reissuance of all Eligible Options at an exercise price of $1.72 per share. Following the repricing, each Eligible Option retains its respective original vesting schedule and expiration date."}],"balance_after":0,"derivative":{"exercise_price":9.54,"expiration_date":"2029-10-11","underlying":"Common Stock","underlying_shares":19973},"source":{"system":"sec-edgar","filing":"0001193805-24-000325","document":"e619339_4-howson.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1280776/000119380524000325/e619339_4-howson.xml","form_type":"4"}},{"id":1761059,"issuer":{"id":7396,"kind":"organization","name":"Lite Strategy, Inc."},"owners":[{"id":17364,"kind":"person","name":"HOWSON TAMAR D","position":1,"cik":"0001202286","reported_name":"HOWSON TAMAR D","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2023-10-12T23:40:49.000Z","date":"2023-09-29","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Such option shall vest as follows: 16.66666% shall be vested on the date of grant, and the remaining shares subject to the option shall vest in equal monthly amounts beginning October 1, 2023 and continuing on the first day of each calendar month following such date and continuing through July 1, 2024."}],"balance_after":10000,"derivative":{"exercise_price":7.01,"expiration_date":"2033-09-29","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0000929638-23-002770","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1262104/000092963823002770/form4.xml","form_type":"4"}},{"id":1841926,"issuer":{"id":6306,"kind":"organization","name":"IMMUNIC, INC."},"owners":[{"id":17364,"kind":"person","name":"HOWSON TAMAR D","position":1,"cik":"0001202286","reported_name":"HOWSON TAMAR D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2023-06-29T20:50:03.000Z","date":"2023-06-28","kind":"grant","planned":false,"acquired":true,"shares":16000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in monthly increments over a period of one year from the grant date."}],"balance_after":16000,"derivative":{"exercise_price":1.94,"expiration_date":"2033-06-28","underlying":"Common Stock","underlying_shares":16000},"source":{"system":"sec-edgar","filing":"0001193805-23-000923","document":"e618746_4-howson.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1280776/000119380523000923/e618746_4-howson.xml","form_type":"4"}},{"id":2062029,"issuer":{"id":6301,"kind":"organization","name":"Cue Biopharma, Inc.","symbol":"CUE"},"owners":[{"id":17364,"kind":"person","name":"HOWSON TAMAR D","position":1,"cik":"0001202286","reported_name":"HOWSON TAMAR D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-01-05T21:09:28.000Z","date":"2023-01-03","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a stock option award granted pursuant to the Issuer's Director Compensation Policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was granted on January 3, 2023.  The shares underlying the option are scheduled to vest in full on the anniversary date of the grant date."}],"balance_after":10000,"derivative":{"exercise_price":2.66,"expiration_date":"2033-01-02","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-23-001785","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1202286/000120919123001785/doc4.xml","form_type":"4"}},{"id":2210652,"issuer":{"id":7396,"kind":"organization","name":"Lite Strategy, Inc."},"owners":[{"id":17364,"kind":"person","name":"HOWSON TAMAR D","position":1,"cik":"0001202286","reported_name":"HOWSON TAMAR D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-07-07T20:26:29.000Z","date":"2022-07-05","kind":"grant","acquired":true,"shares":87500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options will vest in equal monthly installments over twelve months."}],"balance_after":87500,"derivative":{"exercise_price":0.54,"expiration_date":"2032-07-05","underlying":"Common Stock","underlying_shares":87500},"source":{"system":"sec-edgar","filing":"0000899243-22-025710","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1262104/000089924322025710/doc4.xml","form_type":"4"}},{"id":2227382,"issuer":{"id":6306,"kind":"organization","name":"IMMUNIC, INC."},"owners":[{"id":17364,"kind":"person","name":"HOWSON TAMAR D","position":1,"cik":"0001202286","reported_name":"HOWSON TAMAR D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2022-06-18T01:31:34.000Z","date":"2022-06-15","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in monthly increments over a period of one year from the grant date."}],"balance_after":10000,"derivative":{"exercise_price":3.4,"expiration_date":"2032-06-15","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001193805-22-000967","document":"e621754_4-howson.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1280776/000119380522000967/e621754_4-howson.xml","form_type":"4"}},{"id":2443242,"issuer":{"id":6301,"kind":"organization","name":"Cue Biopharma, Inc.","symbol":"CUE"},"owners":[{"id":17364,"kind":"person","name":"HOWSON TAMAR D","position":1,"cik":"0001202286","reported_name":"HOWSON TAMAR D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-01-06T01:24:22.000Z","date":"2022-01-03","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a stock option award granted pursuant to the Issuer's Director Compensation Policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was granted on January 3, 2022.  The shares underlying the option are scheduled to vest in full on the anniversary of the grant date."}],"balance_after":10000,"derivative":{"exercise_price":12.28,"expiration_date":"2032-01-02","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0000899243-22-001050","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1202286/000089924322001050/doc4.xml","form_type":"4"}},{"id":2640859,"issuer":{"id":7396,"kind":"organization","name":"Lite Strategy, Inc."},"owners":[{"id":17364,"kind":"person","name":"HOWSON TAMAR D","position":1,"cik":"0001202286","reported_name":"HOWSON TAMAR D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-07-06T23:00:43.000Z","date":"2021-07-01","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options will vest in equal monthly installments over twelve months."}],"balance_after":50000,"derivative":{"exercise_price":2.95,"expiration_date":"2031-07-01","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001209191-21-045660","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1262104/000120919121045660/doc4.xml","form_type":"4"}},{"id":2669940,"issuer":{"id":6306,"kind":"organization","name":"IMMUNIC, INC."},"owners":[{"id":17364,"kind":"person","name":"HOWSON TAMAR D","position":1,"cik":"0001202286","reported_name":"HOWSON TAMAR D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2021-06-14T21:02:11.000Z","date":"2021-06-10","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in monthly increments over a period of one year from the grant date."}],"balance_after":10000,"derivative":{"exercise_price":14.77,"expiration_date":"2031-06-10","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001193805-21-000867","document":"e620711_4-howson.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1280776/000119380521000867/e620711_4-howson.xml","form_type":"4"}},{"id":2915028,"issuer":{"id":6301,"kind":"organization","name":"Cue Biopharma, Inc.","symbol":"CUE"},"owners":[{"id":17364,"kind":"person","name":"HOWSON TAMAR D","position":1,"cik":"0001202286","reported_name":"HOWSON TAMAR D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-01-06T21:39:06.000Z","date":"2021-01-04","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a stock option award granted pursuant to the Issuer's Director Compensation Policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was granted on January 4, 2021. The shares underlying the option are scheduled to vest in full on the anniversary of the grant date."}],"balance_after":10000,"derivative":{"exercise_price":12.36,"expiration_date":"2031-01-03","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0000899243-21-000700","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1202286/000089924321000700/doc4.xml","form_type":"4"}},{"id":3026738,"issuer":{"id":6301,"kind":"organization","name":"Cue Biopharma, Inc.","symbol":"CUE"},"owners":[{"id":17364,"kind":"person","name":"HOWSON TAMAR D","position":1,"cik":"0001202286","reported_name":"HOWSON TAMAR D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-09-18T20:15:14.000Z","date":"2020-09-17","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option grant becomes exercisable in eight equal semi-annual installments beginning March 17, 2021."}],"balance_after":50000,"derivative":{"exercise_price":17.21,"expiration_date":"2030-09-17","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001209191-20-051145","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1202286/000120919120051145/doc4.xml","form_type":"4"}},{"id":3087332,"issuer":{"id":7396,"kind":"organization","name":"Lite Strategy, Inc."},"owners":[{"id":17364,"kind":"person","name":"HOWSON TAMAR D","position":1,"cik":"0001202286","reported_name":"HOWSON TAMAR D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-07-07T17:12:42.000Z","date":"2020-07-02","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options will vest in equal monthly installments over twelve months."}],"balance_after":50000,"derivative":{"exercise_price":3.49,"expiration_date":"2030-07-02","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0000899243-20-018612","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1262104/000089924320018612/doc4.xml","form_type":"4"}},{"id":3088555,"issuer":{"id":6306,"kind":"organization","name":"IMMUNIC, INC."},"owners":[{"id":17364,"kind":"person","name":"HOWSON TAMAR D","position":1,"cik":"0001202286","reported_name":"HOWSON TAMAR D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2020-07-07T00:18:23.000Z","date":"2020-07-02","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in monthly increments over a period of one year from the grant date."}],"balance_after":15000,"derivative":{"exercise_price":12.3,"expiration_date":"2030-07-01","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001193805-20-000799","document":"e619752_4-howson.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1280776/000119380520000799/e619752_4-howson.xml","form_type":"4"}},{"id":3393573,"issuer":{"id":6306,"kind":"organization","name":"IMMUNIC, INC."},"owners":[{"id":17364,"kind":"person","name":"HOWSON TAMAR D","position":1,"cik":"0001202286","reported_name":"HOWSON TAMAR D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2019-10-15T21:02:02.000Z","date":"2019-10-11","kind":"grant","acquired":true,"shares":29959,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option to purchase 9,986 shares vests in monthly increments over a period of one year from the grant date, and the option to purchase 19,973 shares vests in monthly increments over a period of three years from the grant date."}],"balance_after":29959,"derivative":{"exercise_price":9.54,"expiration_date":"2029-10-11","underlying":"Common Stock","underlying_shares":29959},"source":{"system":"sec-edgar","filing":"0001193805-19-001345","document":"e619122_4-howson.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1280776/000119380519001345/e619122_4-howson.xml","form_type":"4"}},{"id":3467663,"issuer":{"id":7396,"kind":"organization","name":"Lite Strategy, Inc."},"owners":[{"id":17364,"kind":"person","name":"HOWSON TAMAR D","position":1,"cik":"0001202286","reported_name":"HOWSON TAMAR D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-07-03T19:30:14.000Z","date":"2019-07-01","kind":"grant","acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"20,000 options will vest in equal monthly installments over thirty-six months, and 40,000 of the options will vest in equal monthly installments over twelve months."}],"balance_after":60000,"derivative":{"exercise_price":2.52,"expiration_date":"2029-07-01","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001209191-19-040974","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1262104/000120919119040974/doc4.xml","form_type":"4"}},{"id":3859068,"issuer":{"id":8386,"kind":"organization","name":"VivoSim Labs, INC."},"owners":[{"id":17364,"kind":"person","name":"HOWSON TAMAR D","position":1,"cik":"0001202286","reported_name":"HOWSON TAMAR D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-07-30T20:54:10.000Z","date":"2018-07-26","kind":"grant","acquired":true,"shares":45500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shares vest and become exercisable in full on the earlier of (i) July 26, 2019 or (ii) immediately prior to commencement of the Issuer's next annual stockholder meeting."}],"balance_after":45550,"derivative":{"exercise_price":1.29,"expiration_date":"2028-07-26","underlying":"Common Stock","underlying_shares":45550},"source":{"system":"sec-edgar","filing":"0001209191-18-044419","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1497253/000120919118044419/doc4.xml","form_type":"4"}},{"id":4223476,"issuer":{"id":8386,"kind":"organization","name":"VivoSim Labs, INC."},"owners":[{"id":17364,"kind":"person","name":"HOWSON TAMAR D","position":1,"cik":"0001202286","reported_name":"HOWSON TAMAR D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-08-28T20:35:28.000Z","date":"2017-08-24","kind":"grant","acquired":true,"shares":42500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shares vest and become exercisable in full on the earlier of (i) August 24, 2018 or (ii) immediately prior to commencement of the Issuer's next annual stockholder meeting."}],"balance_after":42500,"derivative":{"exercise_price":1.97,"expiration_date":"2027-08-24","underlying":"Common Stock","underlying_shares":42500},"source":{"system":"sec-edgar","filing":"0001209191-17-050406","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1497253/000120919117050406/doc4.xml","form_type":"4"}},{"id":4354324,"issuer":{"id":8208,"kind":"organization","name":"Hepion Pharmaceuticals, Inc.","symbol":"HEPA"},"owners":[{"id":17364,"kind":"person","name":"HOWSON TAMAR D","position":1,"cik":"0001202286","reported_name":"HOWSON TAMAR D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2017-04-11T20:02:43.000Z","date":"2017-04-10","kind":"grant","acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options vest in three installments as follows: 11,667 of the options vest on each of April 10, 2018 and 2019 and 11,666 vest on April 10, 2020."}],"balance_after":80000,"derivative":{"exercise_price":1.6,"expiration_date":"2027-04-10","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001104659-17-022871","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1202286/000110465917022871/a4.xml","form_type":"4"}},{"id":591352,"issuer":{"id":1662,"kind":"organization","name":"BRISTOL MYERS SQUIBB CO","symbol":"BMY"},"owners":[{"id":17364,"kind":"person","name":"HOWSON TAMAR D","position":1,"cik":"0001202286","reported_name":"HOWSON TAMAR D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Corp & Bus Development"}}],"security":"Executive Option (right to buy)","published_at":"2006-12-04T19:39:02.000Z","date":"2006-12-01","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Option is not exercisable until the closing share price of common stock achieves a price of at least 15% above the option grant price and remains at that price for seven consecutive trading days.  Shares vest one-third per year, on a cumulative basis, on the third, fourth, and fifth anniversaries of the grant date."}],"balance_after":100000,"derivative":{"exercise_price":24.74,"expiration_date":"2016-11-30","underlying":"Common Stock, $0.10 par value","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0000014272-06-000229","document":"how633.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/14272/000001427206000229/how633.xml","form_type":"4"}},{"id":591351,"issuer":{"id":1662,"kind":"organization","name":"BRISTOL MYERS SQUIBB CO","symbol":"BMY"},"owners":[{"id":17364,"kind":"person","name":"HOWSON TAMAR D","position":1,"cik":"0001202286","reported_name":"HOWSON TAMAR D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Corp & Bus Development"}}],"security":"Common Stock, $0.10 par value","published_at":"2006-12-04T19:39:02.000Z","date":"2006-12-01","kind":"tax_withholding","acquired":false,"shares":3038,"price":24.74,"value":75160.12,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld for payment of taxes upon vesting of restricted stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of restricted stock with one-third vesting on each of the third, fourth and fifth anniversaries of the grant date."}],"balance_after":71465,"source":{"system":"sec-edgar","filing":"0000014272-06-000229","document":"how633.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/14272/000001427206000229/how633.xml","form_type":"4"}},{"id":598880,"issuer":{"id":1662,"kind":"organization","name":"BRISTOL MYERS SQUIBB CO","symbol":"BMY"},"owners":[{"id":17364,"kind":"person","name":"HOWSON TAMAR D","position":1,"cik":"0001202286","reported_name":"HOWSON TAMAR D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Corp & Bus Development"}}],"security":"Common Stock, $0.10 par value","published_at":"2006-09-12T20:38:55.000Z","date":"2006-09-08","kind":"tax_withholding","acquired":false,"shares":1215,"price":22.96,"value":27896.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld for payment of taxes upon vesting of restricted stock."}],"balance_after":74503,"source":{"system":"sec-edgar","filing":"0000014272-06-000185","document":"how596.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/14272/000001427206000185/how596.xml","form_type":"4"}},{"id":607317,"issuer":{"id":1662,"kind":"organization","name":"BRISTOL MYERS SQUIBB CO","symbol":"BMY"},"owners":[{"id":17364,"kind":"person","name":"HOWSON TAMAR D","position":1,"cik":"0001202286","reported_name":"HOWSON TAMAR D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Corp & Bus Development"}}],"security":"Common Stock, $0.10 par value","published_at":"2006-05-24T15:09:29.000Z","date":"2006-05-22","kind":"tax_withholding","acquired":false,"shares":3038,"price":24.16,"value":73398.08,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld for payment of taxes upon vesting of restricted stock."}],"balance_after":75718,"source":{"system":"sec-edgar","filing":"0000014272-06-000147","document":"how566.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/14272/000001427206000147/how566.xml","form_type":"4"}},{"id":615117,"issuer":{"id":1662,"kind":"organization","name":"BRISTOL MYERS SQUIBB CO","symbol":"BMY"},"owners":[{"id":17364,"kind":"person","name":"HOWSON TAMAR D","position":1,"cik":"0001202286","reported_name":"HOWSON TAMAR D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Corp & Bus Development"}}],"security":"Executive Option (right to buy)","published_at":"2006-03-09T22:09:54.000Z","date":"2006-03-07","kind":"grant","acquired":true,"shares":33915,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Option is not exercisable until the closing share price of common stock achieves a price of at least 15% above the option grant price and remains at that price for seven consecutive trading days.  Option vests 25% of the shares annually, on a cumulative basis, commencing one year after the date of grant, but may not be exercised until the threshold is satisfied."}],"balance_after":33915,"derivative":{"exercise_price":22.73,"expiration_date":"2016-03-06","underlying":"Common Stock, $0.10 par value","underlying_shares":33915},"source":{"system":"sec-edgar","filing":"0000014272-06-000100","document":"how530.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/14272/000001427206000100/how530.xml","form_type":"4"}},{"id":615116,"issuer":{"id":1662,"kind":"organization","name":"BRISTOL MYERS SQUIBB CO","symbol":"BMY"},"owners":[{"id":17364,"kind":"person","name":"HOWSON TAMAR D","position":1,"cik":"0001202286","reported_name":"HOWSON TAMAR D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Corp & Bus Development"}}],"security":"Common Stock, $0.10 par value","published_at":"2006-03-09T22:09:54.000Z","date":"2006-03-07","kind":"tax_withholding","acquired":false,"shares":1862,"price":22.73,"value":42323.26,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Shares withheld for payment of taxes."}],"balance_after":78756,"source":{"system":"sec-edgar","filing":"0000014272-06-000100","document":"how530.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/14272/000001427206000100/how530.xml","form_type":"4"}},{"id":615115,"issuer":{"id":1662,"kind":"organization","name":"BRISTOL MYERS SQUIBB CO","symbol":"BMY"},"owners":[{"id":17364,"kind":"person","name":"HOWSON TAMAR D","position":1,"cik":"0001202286","reported_name":"HOWSON TAMAR D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Corp & Bus Development"}}],"security":"Common Stock, $0.10 par value","published_at":"2006-03-09T22:09:54.000Z","date":"2006-03-07","kind":"grant","acquired":true,"shares":5107,"price":22.73,"value":116082.11,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Consists of shares earned as long-term performance awards under the 2002 Stock Incentive Plan."}],"balance_after":80618,"source":{"system":"sec-edgar","filing":"0000014272-06-000100","document":"how530.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/14272/000001427206000100/how530.xml","form_type":"4"}},{"id":615114,"issuer":{"id":1662,"kind":"organization","name":"BRISTOL MYERS SQUIBB CO","symbol":"BMY"},"owners":[{"id":17364,"kind":"person","name":"HOWSON TAMAR D","position":1,"cik":"0001202286","reported_name":"HOWSON TAMAR D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Corp & Bus Development"}}],"security":"Common Stock, $0.10 par value","published_at":"2006-03-09T22:09:54.000Z","date":"2006-03-07","kind":"grant","acquired":true,"shares":8085,"price":22.73,"value":183772.05,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares consist of restricted stock with one-third vesting on each of the third, fourth and fifth anniversaries of the grant date."}],"balance_after":75511,"source":{"system":"sec-edgar","filing":"0000014272-06-000100","document":"how530.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/14272/000001427206000100/how530.xml","form_type":"4"}},{"id":626302,"issuer":{"id":1662,"kind":"organization","name":"BRISTOL MYERS SQUIBB CO","symbol":"BMY"},"owners":[{"id":17364,"kind":"person","name":"HOWSON TAMAR D","position":1,"cik":"0001202286","reported_name":"HOWSON TAMAR D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Corp & Bus Development"}}],"security":"Common Stock, $0.10 par value","published_at":"2005-12-06T20:31:42.000Z","date":"2005-12-02","kind":"tax_withholding","acquired":false,"shares":3294,"price":21.69,"value":71446.86,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld for payment of taxes upon vesting of restricted stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of restricted stock with one-third vesting on each of the third, fourth and fifth anniversaries of the grant date."}],"balance_after":67426,"source":{"system":"sec-edgar","filing":"0000014272-05-000199","document":"how467.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/14272/000001427205000199/how467.xml","form_type":"4"}},{"id":639447,"issuer":{"id":1662,"kind":"organization","name":"BRISTOL MYERS SQUIBB CO","symbol":"BMY"},"owners":[{"id":17364,"kind":"person","name":"HOWSON TAMAR D","position":1,"cik":"0001202286","reported_name":"HOWSON TAMAR D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Corp & Bus Development"}}],"security":"Common Stock, $0.10 par value","published_at":"2005-05-23T17:03:05.000Z","date":"2005-05-20","kind":"tax_withholding","acquired":false,"shares":2460,"price":25.64,"value":63074.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld for payment of taxes upon vesting of restricted stock."}],"balance_after":70720,"source":{"system":"sec-edgar","filing":"0000014272-05-000123","document":"how399.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/14272/000001427205000123/how399.xml","form_type":"4"}},{"id":644767,"issuer":{"id":1662,"kind":"organization","name":"BRISTOL MYERS SQUIBB CO","symbol":"BMY"},"owners":[{"id":17364,"kind":"person","name":"HOWSON TAMAR D","position":1,"cik":"0001202286","reported_name":"HOWSON TAMAR D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Corp & Bus Development"}}],"security":"Executive Option (right to buy)","published_at":"2005-03-03T22:33:54.000Z","date":"2005-03-01","kind":"grant","acquired":true,"shares":46667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Option is not exercisable until the earlier of (i) the closing share price of common stock achieving a price of at least 15% above the option grant price and remaining at that price for seven consecutive trading days or (ii) the ninth anniversary of the grant date.  Shares underlying option vest 25% a year, on a cumulative basis, commencing one year after the date of grant."}],"balance_after":46667,"derivative":{"exercise_price":25.45,"expiration_date":"2015-02-28","underlying":"Common Stock, $0.10 par value","underlying_shares":46667},"source":{"system":"sec-edgar","filing":"0000014272-05-000072","document":"how365.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/14272/000001427205000072/how365.xml","form_type":"4"}},{"id":644766,"issuer":{"id":1662,"kind":"organization","name":"BRISTOL MYERS SQUIBB CO","symbol":"BMY"},"owners":[{"id":17364,"kind":"person","name":"HOWSON TAMAR D","position":1,"cik":"0001202286","reported_name":"HOWSON TAMAR D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Corp & Bus Development"}}],"security":"Common Stock, $0.10 par value","published_at":"2005-03-03T22:33:54.000Z","date":"2005-03-01","kind":"grant","acquired":true,"shares":7778,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares consist of restricted stock with one-third vesting on each of the third, fourth and fifth anniversaries of the grant date."}],"balance_after":73180,"source":{"system":"sec-edgar","filing":"0000014272-05-000072","document":"how365.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/14272/000001427205000072/how365.xml","form_type":"4"}},{"id":650041,"issuer":{"id":1662,"kind":"organization","name":"BRISTOL MYERS SQUIBB CO","symbol":"BMY"},"owners":[{"id":17364,"kind":"person","name":"HOWSON TAMAR D","position":1,"cik":"0001202286","reported_name":"HOWSON TAMAR D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Corp & Bus Development"}}],"security":"Common Stock, $0.10 par value","published_at":"2004-12-06T19:21:16.000Z","date":"2004-12-03","kind":"tax_withholding","acquired":false,"shares":2460,"price":24.06,"value":59187.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld for payment of taxes upon vesting of restricted stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of restricted stock with one-third vesting on each of the third, fourth and fifth anniversaries of the grant date."}],"balance_after":65402,"source":{"system":"sec-edgar","filing":"0000014272-04-000196","document":"how322.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/14272/000001427204000196/how322.xml","form_type":"4"}},{"id":659596,"issuer":{"id":1662,"kind":"organization","name":"BRISTOL MYERS SQUIBB CO","symbol":"BMY"},"owners":[{"id":17364,"kind":"person","name":"HOWSON TAMAR D","position":1,"cik":"0001202286","reported_name":"HOWSON TAMAR D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Corp & Bus Development"}}],"security":"Option (right to buy)","published_at":"2004-03-04T22:25:35.000Z","date":"2004-03-02","kind":"grant","acquired":true,"shares":46667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Exercisable as to 25% of the shares annually, on a cumulative basis, commencing one year after the date of grant."}],"balance_after":46667,"derivative":{"exercise_price":28.11,"expiration_date":"2014-03-01","underlying":"Common Stock, $0.10 par value","underlying_shares":46667},"source":{"system":"sec-edgar","filing":"0000014272-04-000073","document":"how231.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/14272/000001427204000073/how231.xml","form_type":"4"}},{"id":659595,"issuer":{"id":1662,"kind":"organization","name":"BRISTOL MYERS SQUIBB CO","symbol":"BMY"},"owners":[{"id":17364,"kind":"person","name":"HOWSON TAMAR D","position":1,"cik":"0001202286","reported_name":"HOWSON TAMAR D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Corp & Bus Development"}}],"security":"Common Stock, $0.10 par value","published_at":"2004-03-04T22:25:35.000Z","date":"2004-03-02","kind":"grant","acquired":true,"shares":7778,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares consist of restricted stock with one-third vesting on each of the third, fourth and fifth anniversaries of the grant date."}],"balance_after":67862,"source":{"system":"sec-edgar","filing":"0000014272-04-000073","document":"how231.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/14272/000001427204000073/how231.xml","form_type":"4"}},{"id":667165,"issuer":{"id":1662,"kind":"organization","name":"BRISTOL MYERS SQUIBB CO","symbol":"BMY"},"owners":[{"id":17364,"kind":"person","name":"HOWSON TAMAR D","position":1,"cik":"0001202286","reported_name":"HOWSON TAMAR D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Corp & Bus Development"}}],"security":"Common Stock, $0.10 par value","published_at":"2003-09-12T19:16:39.000Z","date":"2003-09-10","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares consist of restricted stock with one-third vesting on each of the third, fourth and fifth anniversaries of the grant date."}],"balance_after":60084,"source":{"system":"sec-edgar","filing":"0000014272-03-000030","document":"how159.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/14272/000001427203000030/how159.xml","form_type":"4"}}]}